← Leaderboards
Emily K Cope
Northern Arizona University
$2,136,067
Attributed
$2,370,303
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $547.4K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,370,303 · 4
By mechanism
U54$1,483,831 · 2
R15$468,472 · 1
R21$418,000 · 1
Top collaborators
- James Gregory Caporaso1 shared
Most similar at Northern Arizona University
Same institution · by research overlap
- James Gregory Caporaso$4,210,634
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposIn VivoMicrobiotaHost-Associated Microbial CommunitiesMicrobialEcologyInflammatoryMicrobiomeImmune SystemGut MicrobiotaProductionImmuneVolatile Fatty AcidsGut MicrobiomeMicrobiome CompositionAsthmatic PatientLinkAirway InflammationChronicIn VitroLungCellsAsthmaticAsthma
Grant awards (7)
Evaluation of Soluble Fiber as a Strategy to Decrease Asthma Morbidity in Pediatric Populations$462,653
U54 · FY2025 · MD · contact PI
Evaluation of Soluble Fiber as a Strategy to Decrease Asthma Morbidity in Underserved Populations$328,420
U54 · FY2024 · MD · contact PI
Evaluation of Soluble Fiber as a Strategy to Decrease Asthma Morbidity in Underserved Populations$335,314
U54 · FY2023 · MD · contact PI
Evaluation of Soluble Fiber as a Strategy to Decrease Asthma Morbidity in Underserved Populations$357,444
U54 · FY2022 · MD · contact PI
Development of in vivo quantitative stable isotope probing to quantify microbiome dynamics in Alzheimers Disease$190,000
R21 · FY2022 · AG · contact PI
Development of in vivo quantitative stable isotope probing to quantify microbiome dynamics in Alzheimers Disease$228,000
R21 · FY2021 · AG · contact PI
Determining the Role of the Upper and Lower Airway Microbiota as Drivers of Concomitant Inflammatory Responses in patients with Chronic Rhinosinusitis and Asthma$468,472
R15 · FY2019 · AI · contact PI